HLL signs pact with Maha Govt to set up diagnostic labs

Image
Press Trust of India Mumbai
Last Updated : Feb 09 2017 | 3:57 PM IST
Expanding its Hindlabs chain of pathology and imaging facilities, public sector HLL Lifecare Ltd has signed an agreement with the Maharashtra government for providing diagnostic services in state-run health facilities.
The agreement was signed by R P Khandelwal, CMD, HLL, Dr. Pradeep Vyas, Commissioner and MD, SHS, and Dr Sathish Pawar, Director of Health Services), in Mumbai the other day.
As part of the agreement, HLL, a 'mini Ratna' PSU of the Union Ministry of Health and Family Welfare (MoHFW), will establish around 100 Hindlabs in 33 districts of Maharashtra for providing laboratory testing services in nearly 2,300 t hospitals under DHS, particularly at the level of Primary Health Centres (PHCs), a HLL release said today.
HLL will implement the project within a period of 90 days, commencing the lab services to the general public.
The project will be monitored by IT-enabled systems which track the details of patients' samples taken from the collection centres to the lab for testing and reporting.
The latest module of laboratory information system software will be used for the project to create an online dash board to view the current status of sample collection, testing and reporting from all the government hospital centers in Maharashtra.
"By implementing this project, diagnostic tests will be made available to the public in the remotest villages of Maharashtra. The labs of HLL, with sophisticated equipment, qualified manpower and IT-enabled support systems, will ensure the quality of laboratory investigations," Khandelwal said.
The labs being set up under the project will have all the divisions like hematology, pathology, biochemistry, immunoassay and microbiology, he said.
HLL is implementing similar projects in Assam, Kerala and Odisha, partnering with National Health Mission (NHM). Hindlabs offers more than 100 tests from the hospital centres, including the high end special molecular diagnostic tests, at rates much lower than market prices.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 09 2017 | 3:57 PM IST

Next Story